ACHN News 6.83 07/23/2014 04:23:42 Achillion Pharmaceuticals

New Post Public Reply Private Reply Replies (0) Message Board

Jul 23, 2014 at 5:23 AM

Achillion Pharmaceuticals (ACHN) 6.83 $ACHN

Critical Alerts For Exelixis, Rocket Fuel, Netflix, Johnson & Johnson, and Achillion Pharmaceuticals Released By InvestorsObserver
PR Newswire - Tue Jul 15, 8:31AM CDT
InvestorsObserver issues critical PriceWatch Alerts for EXEL, FUEL, NFLX, JNJ, and ACHN.

Why American Apparel, Glu Mobile, and Achillion Pharmaceuticals Are Today's 3 Best Stocks
Sean Williams, The Motley Fool - Motley Fool - Fri Jul 11, 4:15PM CDT
We haven't been able to say this often recently, but the broad-based S&P 500 limped into Friday's close with a modest gain, but still finished the week lower by nearly 1%. As is typical with most Fridays, economic data was fairly light....

Nasdaq stocks posting largest percentage increases
AP - Fri Jul 11, 12:38PM CDT
NEW YORK (AP) — A look at the 10 biggest percentage gainers on Nasdaq at 1 p.m.:

Technical Data on Health Care Sector Equities -- Research on Achillion Pharma, Novavax, Dendreon, and Exelixis
PR Newswire - Thu Jul 10, 6:00AM CDT
On Wednesday, July 09, 2014, the NASDAQ Composite ended at 4,419.03, up 0.63%, the Dow Jones Industrial Average advanced 0.47%, to finish the day at 16,985.61, and the S&P 500 closed at 1,972.83, up 0.46%. The gains were broad based with nine out of ten sectors ending the session in positive. The S&P 500 Health Care Sector Index ended the day at 712.05, up 0.38%, with the index advancing 5.76% in the previous three months. Investor-Edge has initiated coverage on the following equities: Achillion Pharmaceuticals Inc. (NASDAQ: ACHN), Novavax Inc. (NASDAQ: NVAX), Dendreon Corp. (NASDAQ: DNDN) and Exelixis Inc. (NASDAQ: EXEL). Free technical research on ACHN, NVAX, DNDN and EXEL can be downloaded upon signing up at:

Agreements, NDA Submissions, FDA Approvals, Enrollment Updates, and Index Inclusions - Analyst Notes on Jazz Pharmaceuticals, Vertex, NPS, StemCells and Achillion
PR Newswire - Mon Jul 07, 4:50AM CDT
Today, Analysts Review released its analysts' notes regarding Jazz Pharmaceuticals plc (NASDAQ: JAZZ), Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX), NPS Pharmaceuticals, Inc. (NASDAQ: NPSP), StemCells, Inc. (NASDAQ: STEM) and Achillion Pharmaceuticals, Inc. (NASDAQ: ACHN). Private wealth members receive these notes ahead of publication. To reserve complementary membership, limited openings are available at: http://www.analystsreview.com/4482-100free.

The 5 Best Healthcare Stocks so Far in 2014
Todd Campbell, The Motley Fool - Motley Fool - Sun Jul 06, 8:30AM CDT
Healthcare stocks put up impressive returns last year and are trumping the S&P 500 yet again this year. The S&P health care select index ETF (XLV) is up more than 10% this year and the iShares Nasdaq biotechnology ETF (IBB) has gained...

Achillion Pharmaceuticals Added to the Russell 2000 and Russell Microcap Indexes
GlobeNewswire - Tue Jul 01, 3:05PM CDT
Achillion Pharmaceuticals, Inc. (Nasdaq:ACHN) announced that it has been added to the Russell 2000 and Russell Microcap Indexes. Each June, Russell realigns its family of global equity indexes to reflect market changes in the past year.

3 Stocks With Eye-Popping Gains This Month
Todd Campbell, The Motley Fool - Motley Fool - Mon Jun 30, 2:12PM CDT
Shares in biotechnology companies can make breathtaking moves higher and lower on whims and whispers, and June was no exception. Following the sector's rollicking ride higher last year and dramatic sell-off in the first quarter, investors are right...

Achillion
at Investor's Business Daily - Fri Jun 20, 5:38PM CDT
Achillion (ACHN) shares rose 0.6% to 8.13 after R. W. Baird noted that Merck's (MRK) official tender offer indicated that there was another bidder for Idenix Pharmaceuticals, which means that a company is still looking for a nucleoside hepatitis C...

Achillion Could Win Idenix's Mystery Suitor: Analyst
at Investor's Business Daily - Fri Jun 20, 11:44AM CDT
Hot biotech stock Achillion Pharmaceuticals (ACHN) was up 2%, near 8.20, in midday trading in the stock market today after an analyst found more support for its prospects as a buyout candidate. R. W. Baird's Brian Skorney noted that Merck's (MRK)...

The Zacks Analyst Blog Highlights: Idenix, Achillion Pharmaceuticals, Nektar, Orexigen, Celgene, Alexion and Biogen
PR Newswire - Thu Jun 19, 8:30AM CDT
Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include the Idenix (Nasdaq:IDIX-Free Report), Achillion Pharmaceuticals (Nasdaq:ACHN-Free Report), Nektar (Nasdaq:NKTR-Free Report), Orexigen (Nasdaq:OREX-Free Report), Celgene (Nasdaq:CELG-Free Report), Alexion (Nasdaq:ALXN-Free Report) and Biogen (Nasdaq:BIIB-Free Report).

Biotech Stock Roundup: HCV Back in Focus - Idenix, Achillion Soar - Analyst Blog
Arpita Dutt - Zacks Investment Research - Wed Jun 18, 9:33AM CDT
It was about hepatitis C cirus (HCV) treatments and companies last week with the Merck-Idenix acquisition announcement grabbing eyeballs.

Nasdaq stocks posting largest volume increases
AP - Tue Jun 17, 5:03PM CDT
NEW YORK (AP) — A look at the 10 biggest volume gainers on Nasdaq at the close of trading:

Most active Nasdaq-traded stocks
AP - Tue Jun 17, 5:03PM CDT
NEW YORK (AP) — A look at Nasdaq 10 most-active stocks at the close of trading:

Critical Alerts For Bank of America, Achillion Pharmaceuticals, Walmart, SunEdison, and Advanced Micro Devices Released By InvestorsObserver
PR Newswire - Tue Jun 17, 8:31AM CDT
InvestorsObserver issues critical PriceWatch Alerts for BAC, ACHN, WMT, SUNE, and AMD.

Achillion Gets Massive Price Target Hike On HCV Drugs
at Investor's Business Daily - Mon Jun 16, 10:18PM CDT
Biotech Achillion Pharmaceuticals (ACHN) got another boost Monday when Maxim Group more than tripled its price target on the stock, sending shares up 21% on the stock market today. After having dinner with company executives, analyst Jason Kolbert...

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

PROYA Skincare Expands to Ulta: A Scientific Ambition

A New Chapter for PROYA Bet you didn't see this one coming: a leading Chinese beauty brand, PROYA, is throwing its hat into the North American skincare ring, rolling out its science-backed skincare line nationwide at Ulta Beauty. The same brand that's been big news across Asia is now setting its sights on the U.S. with a stunning array of products that don't just promise...

Genesys Works Nets Grant to Boost Youth Career Access

A Windfall for Career Readiness Here’s a nugget of hope wrapped in a crisp announcement: Genesys Works, the not-for-profit that’s been busy nuancing the work-play balance for high school kids, is rolling with a $4 million boost from Ballmer Group. This move isn’t just pennies from heaven; it's a strategic play designed to gird young folks for the evolving demands of...

Navigating Idaho's Massage Therapy School Pathways

Cracking the Idaho Massage School Code Idaho folks diving into massage therapy education need a playbook—timing, training, and all the bumps along the way. This journey's not just book reading and back rubs; it’s a structured affair with rigid hours and some bureaucratic hurdling. Thank goodness for Kylee Evans, who’s spilling the beans on what goes down in Idaho...

Lululemon Lawsuit Looms: Investors Face Key Decisions

Seems Lululemon just tripped on its yoga mat. When a company like Lululemon Athletica, Inc (NASDAQ:LULU) sees a 17.38% slide in stock, every savvy investor knows there's more beneath the surface. Squarely in the crosshairs of a securities fraud class action, the brand synonymous with upscale athleisure faces harsh scrutiny. And the deadline's ticking—even the suits know...

VinFast's Radical Mileage Warranty: Game-Changer?

Revving Up: VinFast's Bold Battery Bet Some days it feels like every automaker is just looking for ways to tether drivers to mileage limitations, but VinFast is ripping up the rulebook. Their promise of a 10-year, unlimited-mileage battery warranty has got tongues wagging, and for good reason. Under typical policies, drivers with long commutes or adventurous spirits face...

African Scholars Uncover Cangxi's Cultural Strategies

Discovering Cangxi's Development Playbook Picture this: a band of African scholars deep-diving into China's rural heartland, Cangxi, in Sichuan province, trying to unlock the secrets behind its impressive cultural and industrial achievements. On November 4, a delegation from the Horn of Africa arrived as part of a training workshop organized by China's Ministry of Foreign...

CytoSorbents Hits Financial Milestone in Q3 2026

CytoSorbents' Financial Turnaround Imagine the smell of fresh opportunity wafting through CytoSorbents’ (NASDAQ:CTSO) corridors this quarter. The company just nudged into positive territory with its operating cash flow, which, let’s be honest, is like finding a nugget of gold amid last year’s rubble of losses. With $43,000 of positive operating cash flow in a world...

HelloNation Elevates Contractors' Expertise at PHCC NC

Times are changing, and the digital landscape keeps morphing—who can keep up? That's exactly what's on the agenda as McKenzie Finkhousen and Alton Baird lead HelloNation into the 2026 PHCC of NC Annual Meeting. This ain't just another LinkedIn meet-up—this is a proper gathering of minds in plumbing, heating, and cooling biz right at Harrah's Cherokee Casino Resort....

DIR Launches WineWalrus: A New Era for Wine Lovers

The Wine Industry's Digital Splash Ah, the wonderful world of wine—a place where culture, taste, and that sweet bouquet of a well-aged vintage collide. It’s no secret that the wine industry is a cash cow, raking in more than $323 billion annually in the U.S. alone. Digital Information Resources (DIR), a savvy player in tech and media circles, decided this bubbling...

Tax Strategies for Small Businesses Before Year-End

Understanding the Importance of Year-Round Tax Planning Every small business owner dreads the tax season—like a thunderstorm on a picnic day. But here's a nugget from Paul Kersten, an Accounting and Tax whiz in Shawano, Wisconsin: don't wait until April to sort your taxes. By then, it's all receipts and regrets. Instead, consider tax planning as a year-long vigil. Why?...